BEL 114055: A Multi-center, Randomized Parallel Group, Placebo-Controlled Double Blind Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date11/30/127/31/13

Funding

  • GlaxoSmithKline LLC